Additional file 1 of Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma

Additional file 1: Table S1. Detailed methylation level of TAGMe in TCGA and GEO datasets. Table S2. Clinical characteristics of the training and validation set. Table S3. Clinical characteristics of the recurrence monitoring set. Table S4. Detailed information of patients in the postoperative high TAGMe group.